These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21544809)

  • 1. Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
    Ter-Minassian M; Asomaning K; Zhao Y; Chen F; Su L; Carmella SG; Lin X; Hecht SS; Christiani DC
    Int J Cancer; 2012 Mar; 130(6):1338-46. PubMed ID: 21544809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG; Borukhova A; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.
    Anderson KE; Carmella SG; Ye M; Bliss RL; Le C; Murphy L; Hecht SS
    J Natl Cancer Inst; 2001 Mar; 93(5):378-81. PubMed ID: 11238699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
    Carmella SG; Han S; Fristad A; Yang Y; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1257-61. PubMed ID: 14652291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
    Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
    Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
    Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
    Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
    Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
    Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.
    Bhat SH; Gelhaus SL; Mesaros C; Vachani A; Blair IA
    Rapid Commun Mass Spectrom; 2011 Jan; 25(1):115-21. PubMed ID: 21154658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.
    Jalas JR; Ding X; Murphy SE
    Drug Metab Dispos; 2003 Oct; 31(10):1199-202. PubMed ID: 12975327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.
    Wiener D; Doerge DR; Fang JL; Upadhyaya P; Lazarus P
    Drug Metab Dispos; 2004 Jan; 32(1):72-9. PubMed ID: 14709623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of nicotine and 4-(methylnitrosamino)-l-(3-pyridyl)-lbutanone (NNK) in menthol and non-menthol cigarette smokers.
    Sarkar M; Wang J; Liang Q
    Drug Metab Lett; 2012 Sep; 6(3):198-206. PubMed ID: 23140558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers.
    Yuan JM; Koh WP; Murphy SE; Fan Y; Wang R; Carmella SG; Han S; Wickham K; Gao YT; Yu MC; Hecht SS
    Cancer Res; 2009 Apr; 69(7):2990-5. PubMed ID: 19318550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
    Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK
    Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.
    Richie JP; Carmella SG; Muscat JE; Scott DG; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):783-90. PubMed ID: 9332760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Michael Meger Irmtrud Meger-Kossien Kirsten Riedel Gerhard Scherer
    Biomarkers; 2000; 5(1):33-45. PubMed ID: 23885904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers.
    Hecht SS; Chung FL; Richie JP; Akerkar SA; Borukhova A; Skowronski L; Carmella SG
    Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):877-84. PubMed ID: 8634661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Zimmerman CL; Wu Z; Upadhyaya P; Hecht SS
    Carcinogenesis; 2004 Jul; 25(7):1237-42. PubMed ID: 14988218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
    Benowitz N; Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2795-800. PubMed ID: 20805316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonyl reduction of NNK by recombinant human lung enzymes: identification of HSD17β12 as the reductase important in (R)-NNAL formation in human lung.
    Ashmore JH; Luo S; Watson CJW; Lazarus P
    Carcinogenesis; 2018 Jul; 39(8):1079-1088. PubMed ID: 29788210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man.
    Richter E; Engl J; Friesenegger S; Tricker AR
    Chem Res Toxicol; 2009 Jun; 22(6):1008-17. PubMed ID: 19408892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.